SCHEMBL30950809

SCHEMBL30950809

OB(O)c1ccc2ncn(CC(F)F)c2n1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.34
TNIK Q9UKE5 1/20 0.33
NPC1 O15118 1/20 0.32
CTSL P07711 1/20 0.32
ELANE P08246 1/20 0.32
CMA1 P23946 1/20 0.32
CTSS P25774 1/20 0.32
CASP1 P29466 1/20 0.32
RAB9A P51151 1/20 0.32
CTSC P53634 1/20 0.32
CTSZ Q9UBR2 1/20 0.32
KLK4 Q9Y5K2 1/20 0.32
FDPS P14324 2/20 0.31
GGPS1 O95749 1/20 0.31
FGFR1 P11362 1/20 0.31
FGFR4 P22455 1/20 0.31
TGFBR1 P36897 1/20 0.30
AGER Q15109 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27246069 1.00 MAPK14 (0.34) MAPK14TNIKNPC1CTSLELANE
SCHEMBL31720195 0.73 ALDH1A1 (0.32)
SCHEMBL25150044 0.72 DYRK1A (0.54) TGFBR1AGERHDAC6
SCHEMBL22125578 0.71 GGPS1 (0.42) MAPK14FDPSGGPS1AGER
SCHEMBL6176928 0.66 ADORA2A (0.44) MAPK14FGFR1FGFR4AGER
SCHEMBL30899626 0.64 GGPS1 (0.43) MAPK14FDPSGGPS1TGFBR1
SCHEMBL25332641 0.63 HCAR1 (0.31)
SCHEMBL31748263 0.63 TDP1 (0.63) FDPSGGPS1AGER
SCHEMBL22125589 0.62 GGPS1 (0.41) MAPK14NPC1CASP1RAB9AFDPS
SCHEMBL28318535 0.62 CDK9 (0.35) TNIKTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4611890-A1 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF BioSplice Therapeutics, Inc. (US) 2025-09-10 EP disclosed
WO-2024097391-A1 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF BIOSPLICE THERAPEUTICS, INC. (US) 2024-05-10 WO disclosed